Snowball logo
logo
PSYB

PsyBio Therapeutics Corp

PSYBF • PINK
$0.00001$0.00  (0%)
Estimate
Beta
-860.167
About the company
Ticker
PSYBF
ISIN
Country
United States of America
Sector (GICS)
Healthcare
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.

Frequently asked questions

What sector does PsyBio Therapeutics Corp (PSYBF) operate in?

PsyBio Therapeutics Corp belongs to the Healthcare sector and operates in the Biotechnology industry.

What is PsyBio Therapeutics Corp (PSYBF) current stock price?

As of the latest data, PsyBio Therapeutics Corp stock price is $0.00, with a previous close of $0.00.

What is PsyBio Therapeutics Corp (PSYBF) current market capitalization?

PsyBio Therapeutics Corp market cap is approximately 808.52.

Does PsyBio Therapeutics Corp (PSYBF) pay dividends?

No. PsyBio Therapeutics Corp does not pay a dividend.

What is PsyBio Therapeutics Corp (PSYBF) beta (volatility) score?

PsyBio Therapeutics Corp has a beta of -860.167, indicating lower volatility than the overall market.